CA45562-3 - 0x000000000000649B

Males & Females of Non-Childbearing Potential

Mountain

* Stipend may pay up to reflected amount.
Start Date: 
January 22, 2025 - 1:45pm
End Date: 
February 6, 2025 - 11:15am

Study Details

Study Number: CA45562
Group Number: 3
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,250.00

Study Criteria

Age: 19 - 55
BMI: 18 - 33
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat Inflammatory Bowel Disease.
Route of Administration: Oral
Blood Draws: 17

Study Schedule

Schedule Type: Short Term
Study Length: 4 Night Stay & 1 Phone Call

Screening Dates:

Event Day Event Date
Thursday 1/16/2025
Tuesday 1/21/2025

Doctor Exam Dates:

Event Day Event Date
Thursday 1/16/2025
Tuesday 1/21/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Wednesday 1/22/2025 1:45:00 PM Saturday 1/25/2025 8:15:00 AM 1 Lincoln
Phone participant Thursday 2/6/2025 11:15:00 AM 1 Lincoln